Open | - |
Close | - |
Volume / Avg. | 0 / 30.270K |
Day Range | - - - |
52 Wk Range | 7.692 - 20.040 |
Market Cap | $64.587M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 1.43% |
Days to Cover | 1.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Assembly Biosciences (NASDAQ: ASMB) through any online brokerage.
Other companies in Assembly Biosciences’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Intensity Therapeutics (NASDAQ:INTS).
The latest price target for Assembly Biosciences (NASDAQ: ASMB) was reported by HC Wainwright & Co. on Friday, March 24, 2023. The analyst firm set a price target for 1.50 expecting ASMB to fall to within 12 months (a possible -87.27% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Assembly Biosciences (NASDAQ: ASMB) is $11.78 last updated March 18, 2024 at 4:07 PM EDT.
There are no upcoming dividends for Assembly Biosciences.
Assembly Biosciences’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Assembly Biosciences.
Assembly Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.